Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.
Publication year
2001Source
Journal of Inherited Metabolic Disease, 24, 5, (2001), pp. 605--6ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Paediatrics - OUD tm 2017
Neurology
Journal title
Journal of Inherited Metabolic Disease
Volume
vol. 24
Issue
iss. 5
Page start
p. 605-
Page end
p. 6
Subject
Disturbances of cerebral development in the young child.; Pediatric Oncology. Treatment of children with cancer.; Pathophysiology of Brain and Behaviour; Cerebrale ontwikkelingsstoornissen bij het jonge kind; Kinderoncologie. Behandeling van kinderen met kanker.; Pathofysiologie van Hersenen en GedragAbstract
An 8 year-old boy with X-ALD under treatment with simvastatin developed a severe adverse reaction when the dose of his other medication, zuclopenthixol was increased. Both drugs were withdrawn after a diagnosis of neuroleptic malignant syndrome was made.
This item appears in the following Collection(s)
- Academic publications [227942]
- Faculty of Medical Sciences [86237]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.